CAMBRIDGE, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Biopure Corporation today announced that company President and CEO Zafiris G. Zafirelis will present at two upcoming investor conferences:
-- MASS Opportunities: A Biotechnology Investment Conference, Thursday, November 3, 2005, 1:20 p.m. eastern time (ET), at the Logan Airport Hilton, Boston, Mass. More information about this conference is available at http://www.massopps.com. -- Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Tuesday, November 8, 2005, 11:55 a.m. ET, at the New York Palace Hotel, New York City. More information about this conference is available at http://www.rodmanandrenshaw.com.
A live webcast of the presentations will be available online via the Investor Relations section of Biopure’s web site at http://www.biopure.com. An archive of the webcast will be available for at least two weeks.
Biopure Corporation
Biopure Corporation develops and manufactures intravenously administered pharmaceuticals, called oxygen therapeutics, that deliver oxygen to the body’s tissues. The company is developing Hemopure(R) [hemoglobin glutamer -- 250 (bovine)], or HBOC-201, for a potential indication in cardiovascular ischemia and, in collaboration with the U.S. Naval Medical Research Center, for an out- of-hospital trauma indication. The product is approved in South Africa for treating surgery patients who are acutely anemic and for eliminating, delaying or reducing allogeneic red blood cell transfusions in these patients. Hemopure has not been approved for sale in other jurisdictions, including the United States or the European Union. Biopure’s veterinary product Oxyglobin(R) [hemoglobin glutamer -- 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs.
Contact: Douglas Sayles (617) 234-6826 Biopure Corporation IR@biopure.com
Biopure Corporation
CONTACT: Douglas Sayles of Biopure Corporation, +1-617-234-6826,IR@biopure.com
Company News On-Call: http://www.prnewswire.com/comp/131224.html/
